---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-034600"
form_type: "8-K"
ticker: null
cik: "0001537561"
company_name: "Arch Therapeutics, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:47:32.136747+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Laurence Hicks resigns from Arch Therapeutics board effective August 28, 2024

## Summary
- Laurence Hicks resigned as Board member on August 28, 2024, effective immediately.
- No disagreements of any kind exist between Mr. Hicks and the company regarding his resignation.
- The filing does not announce a replacement for the departing director.

## SEC filing metadata
- accession: 0001493152-24-034600
- form_type: 8-K
- cik: 0001537561
- company_name: Arch Therapeutics, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1537561/000149315224034600/0001493152-24-034600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1537561/000149315224034600/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-034600
- JSON: https://secwatch.observer/filing/0001493152-24-034600.json
- Plain text: https://secwatch.observer/filing/0001493152-24-034600.txt

## Key facts
- Executive change
  Laurence Hicks resigned as director at Arch Therapeutics, Inc..
  - Action: resigned
  - Role: director
  source text: On August 28, 2024, Laurence Hicks notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 28, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1537561/000149315224034600/0001493152-24-034600-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.